Skip to content
Search

Latest Stories

PDA Union reaches pay agreement with Boots for members

The Pharmacists' Defence Association (PDA) Union has reached a deal for its members working at Boots, covering 6,000 pharmacists employed by the British retailer and pharmacy chain.

As per the agreement, union members working at the multiple will receive a 2 per cent pay rise effective from November 1, 2021, the two entities said in a joint statement.


The settlement, reached under the guidance of Advisory, Conciliation and Arbitration Service (ACAS), covers provisionally registered pharmacists, pharmacists and pharmacist store managers in the bargaining unit for which the PDAU is recognized.

There will be improved benefits for those at the beginning of their careers as “all pharmacists qualifying in 2021 will be paid at least £38k gross FTE, including those who would otherwise be ineligible due to the 1st August cut-off.”

Those who qualified in 2020 will be paid at least £39,000 gross and those qualifying prior to 2020 will be paid at least £40,000 gross.

To promote career pathway for pharmacists to store manager the agreement will ensure a hike in the base starting salary for the pharmacist store manager role to £45,000 gross.

Besides, all eligible pharmacists will get two one off exceptional payments in January 2022 and March 2022 to support their continuous professional development.

There will also be provision for career conversations for all pharmacists at mid-year review to support their individual ambition and meaningful career progression.

Noting the role of pharmacists within local communities and community pharmacies, PDA said: “We value the contribution our pharmacists have made to our patients, communities and our business.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less